共 123 条
[1]
Kaufmann M(2006)Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update J Clin Oncol 24 1940-9
[2]
Hortobagyi GN(1998)Effect of preoperative chemotherapy on the outcome of women with operable breast cancer J Clin Oncol 16 2483-93
[3]
Goldhirsch A(2001)Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902 J Clin Oncol 19 4224-37
[4]
Fisher B(1994)Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: preliminary results of a randomised trial—S6 Eur J Cancer 30A 645-52
[5]
Bryant J(1999)Short and long term effects on survival in breast cancer patients treated by primary chemotherapy: an updated analysis of a randomised trial Breast Cancer Res Treat 58 151-6
[6]
Wolmark N(1995)Breast tumor response to primary chemotherapy predicts local and distant control as well as survival Eur J Cancer 31 1969-75
[7]
van der Hage JA(1999)Clinical course of breast cancer patients with complete pathologic primary and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy J Clin Oncol 17 460-9
[8]
van de Velde CJ(2002)Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancer Br J Cancer 86 1041-106
[9]
Julien JP(2004)The use of alternate, non-cross-resistant adjuvant chemotherapy on the basis of pathologic response to a neoadjuvant doxorubicin-based regimen in women with operable breast cancer: long-term results from a prospective randomized trial J Clin Oncol 22 2294-302
[10]
Scholl SM(1990)Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more J Natl Cancer Inst 82 1539-45